Dear Esteemed Doctors,
Despite the growing body of Real-World Evidence (RWE) demonstrating the efficacy and reduced harm profile of Safer Novel Alternatives (SNAs)—such as those showcased in the October-November issue—the success of any cessation pathway ultimately rests on the quality of the interaction between you and your patient. Research confirms that brief advice from a physician can increase quit rates by up to 30%. However, effectively integrating SNA options requires a nuanced communication strategy that overcomes patient scepticism and tackles existing misconceptions head-on.
Despite the growing body of Real-World Evidence (RWE) demonstrating the efficacy and reduced harm profile of Safer Novel Alternatives (SNAs)—such as those showcased in the October-November issue—the success of any cessation pathway ultimately rests on the quality of the interaction between you and your patient. Research confirms that brief advice from a physician can increase quit rates by up to 30%. However, effectively integrating SNA options requires a nuanced communication strategy that overcomes patient scepticism and tackles existing misconceptions head-on.




